Reading between the lines of the report: target of 40 cents but...

First 5 Last

Share
Profile

Follow
AussieCash

320 Posts.

85

07/09/20

09:38

Post #: 47132819
Share

Originally posted by dbd25 ↑

The Curran & Co report about TNT looks very comprehensive and
well researched, but with a somewhat conservative outlook IMO. C&C seem to
discount TNT's plans for future acquisitions that will be undertaken in Phase 2,
(e.g. in the Prelim Final report 31 Aug - FY21 future focus - "Complete Phase 2 acquisitions").
As many posters have commented, we may assume that this means 2 or more
further acquisitions yet to be announced to the market, if TNT does go ahead
with further expansion.

The C&C report says
"However, we are not forecasting any additional acquisitions and expect that FY22
revenue will grow 42.9% from organic growth drivers alone. "

and

"For the sake of conservatism, we are not assuming any additional purchases,
despite TNT targeting $100m run rate by the end of FY21; future revenue growth
that we forecast is the result of organic drivers such as integration synergies
and Cyber Security market growth."

So I guess if TNT do announce additional acquisitions, the C&C numbers and
valuations in their report will become out of date, and would have to be
adjusted upwards.

All IMHO, DYOR

Expand

Reading between the lines of the report: target of 40 cents but without any new acquisitions/growth accounted for.
Very conservative indeed, as I believe we could easily reach 75 cents before December.

TNT Price at posting: 25.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

GMD

Genesis set for higher gold production in FY25 and earlier mill start

RDN

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

TAT

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

BAS

Bass completes successful testing work at Kiwi-1, showing higher-than-expected condensate yields

EMD

Emyria jumps 10% on 'interim' success treating PTSD patients with MDMA